Nuclear/cytoplasmic ratio correlates strongly with survival in non‐disseminated neuroendocrine carcinoma of the lung

In order to verify whether quantitative morphological indices of neuroendocrine carcinoma of the lung may help to predict survival, 47 biopsies (from 37 males and 10 females; 16–82 years of age) were studied by light microscopy. Areal fractions of nuclei, cytoplasm, stroma, and blood vessels were determined using a standard point counting method. The counts were made in six non‐coincident microscopic fields in each case, and the areal fractions of nuclei, of the entire tumour cell, stroma, blood vessels and the nuclear/cytoplasmic ratio were computed. In a multivariate linear regression analysis, survival in months after biopsy was considered the dependent variable of age and of all morphometric parameters listed above. The significance level was set at 5%. For all patients (disregarding staging) survival was negatively correlated (P< 0.001, multiple r=0.5435) with age and nuclear/cytoplasmic ratio. When only patients with disease confined to the thorax (stages I. II and III) were taken into account, the accuracy of the Function predicting survival increased considerably (P=0.004, multiple r=0.7957). The use of simple stereological methods therefore, proved to be of value in predicting survival in patients with neuroendocrine carcinomas of the lung.

[1]  M. Hammond,et al.  Large cell neuroendocrine tumors of the lung clinical significance and histopathologic definition , 1985, Cancer.

[2]  G. Muscolino,et al.  Surgical Resection in the Treatment of Stages I-II of Small Cell Lung Carcinoma (SCLC) , 1989, Tumori.

[3]  W. Warren,et al.  Reevaluation of pulmonary neoplasms resected as small cell carcinomas. Significance of distinguishing between well‐differentiated and small cell neuroendocrine carcinomas , 1990, Cancer.

[4]  W. Fox,et al.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. , 1973, Lancet.

[5]  R. Holle,et al.  Clinical relevance of histologic subtyping in small cell lung cancer , 1989, Cancer.

[6]  K. Yasumoto,et al.  Surgical treatment of patients with small cell carcinoma of the lung: A histochemical and immunohistochemical study , 1989, Journal of surgical oncology.

[7]  R. Ginsberg,et al.  Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. , 1991, The Journal of thoracic and cardiovascular surgery.

[8]  J. Osinga,et al.  Amplification and expression of different myc‐family genes in a tumor specimen and 3 cell lines derived from one small‐cell lung cancer patient during longitudinal follow‐up , 1989, International journal of cancer.

[9]  W. Warren,et al.  Well differentiated and small cell neuroendocrine carcinomas of the lung , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[10]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  W. Warren,et al.  Neuroendocrine cells and neuroendocrine neoplasms of the lung. , 1983, Pathology annual.

[12]  R. Steele,et al.  Histopathologic classification of small cell lung cancer changing concepts and terminology , 1988, Cancer.

[13]  H. Denz,et al.  Operation for N2 small cell lung carcinoma. , 1990, The Annals of thoracic surgery.